Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]Tyrosine PET

Journal of Nuclear Medicine

Volumn 38, Issue 5, 1997, Pages 692-696

  Kole, Annemieke C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Breast cancer; Carbon 11 tyrosine; Fluorine 18 fdg; PET; Standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TYROSINE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; GLUCOSE METABOLISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BLOOD GLUCOSE; BREAST; BREAST NEOPLASMS; CARBON RADIOISOTOPES; CARCINOMA, DUCTAL, BREAST; DEOXYGLUCOSE; FEMALE; FIBROCYSTIC BREAST DISEASE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; TOMOGRAPHY, EMISSION-COMPUTED; TYROSINE;

EID: 0030947570     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Wahl RL, Cody R, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1991; 179:765-770.
2. Tse NY, Hoh CK, Hawkins RA, et al. The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. Ann Surg 1992-216:27-34.
3. Hoh CK, Hawkins RA, Glaspy JA, et al. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 1993; 17:582-589.
4. Nieweg OE, Wong W, Singletary SE, Hortobagyi GN, Kim EE. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993;71:3920-3925.
5. Adler LP, Crowe JP, Al-Kaisi N A, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 1993; 187:743-750.
6. Bruce DM, Evans NTS, Heys SD, et al. Positron emission tomography: 2-deoxy-2[18F]-fluoro-D-glucose uptake in locally advanced breast cancers. Eur J Surg Oncol 1995;21:280-283.
7. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J NuclMed 1994;35:104-112.
8. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi T, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
9. Ishiwata K, Kubota K. Murakami M. et al. Rc-evaluaiion ofarmno acicl PET studies' can the protein synthesis rates in brain and tumor tissues be measured in vivo?. J Nucl Med 1993:34:1936-1943.
10. Ishiwata K, Kubota K, Murakami M, Kubola R, Senda M. A comparative study on protein incorporation of L-[methyl-3H]methionine, L.-[1-I4C]leucine und E-2[18F]fluorotyrosine in tumor bearing mice. Nucl Med Biol 1993:20:895 899.
11. Bolster JM, Vaalburg W, Paans AMJ, etal. Carbon-11 labelled tyrosincto study tumor metabolism by positron emission tomography (PET). Ew J Nncl Med 1986:12:321 324.
12. 11C]-tyrosine for the visualization of tumors and measurement of the protein synthesis rate. J Nucl Med 1997:38:191 195.
13. Daemen BJ, Elsinga PH, Ishiwata K. Paans AMJ, Vaalburg W. A comparative PET study using different I IC-labelled amino acids in Walker 256 carcinosarcoma-bcaring rats. Int J Radiât Appl Instrum 1991:18:197-204.
14. Willemsen ATM, van Waarde A, Paans AMJ, et al. In vivo protein synthesis rate determination in primary or recurrent brain tumor E-[ 111 C]-tyrosine and PET. J Nucl Med 1995:36:411-419.
15. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850.
16. Hamberg EM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994:35:1308-1312.
17. Keyes JW. SUV: standard uptake or silly useless value? J Nucl Med 1995:36:18361839.
18. Giron C, Euurtsema G, Vos MG, Elsinga PH, Visser GM, Vaalburg W. Microwaveinduced preparation of 11C amino acids via NCA-Bücherer-Strecker synthesis. J Lab Compd Radiopharm 1995;37:752-754.
19. Harnacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrieradded 18F-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophiliesubstitution. J Nucl Med 1986;27:235-238.
20. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. ./ Cereb Blood Flow Metab 1983:3:1-7.
21. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time data. Generalizations. J Cereb Blood Flow Metab 1985;5:584 -590.
22. Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Er J N Mr 1991;65:105-114.
23. Mosteller RD. Simplified calculation of body surface area. N Engl J Med 1987:317: 1098.
24. Eindholm P, Minn H, Eeskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer: a PET study. .1 Nucl Med 1993;34:l-6.
25. Eindholm P, Eeskinen-Kallio S, Kirvela O, et al. Head and neck cancer: effect of food ingestion on uptake of C-ll methionine. Radiology 1994; 190:863-867.
26. 11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med 1988:29:1419-1427.
27. Kubota R, Kubota K, Yamada S, et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 1995:36:484-492.
28. Jansson T, Westlin JE, Ahlström H, Eilja A, Eangström B, Bergh J. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J Clin Oncol 1995:13:1470-1477.
29. Eove SM, Gelman RS, Silen W. Fibrocystic "disease" of the breast: a nondisease? N EnglJ Med 1982;307:1010-1014.
30. Schomburg A, Bender H, Reichel C, et al. Standardized uptake values of fluorine-18 fluorodeoxyglucose: the value of different normalization procedures. Eur J Nucl Med 1996;23:571-574.
31. Miyauchi T. Wahl RE. Regional 2-[lxF]fluoro-2-deoxy-D-glucose uptake varies in normal lung. Eur J Nucl Med 1996:23:517-523.
32. Fischman AJ, Alpert NM. FDG-PET in oncology: there's more to it than looking at pictures. J Nucl Med 1993:34:6-11.
33. Yoshida H, Yoshikawa K, Imazeki K, et al. Correlation analysis between Patlak plot and DAR using 11-C-methionine PET [Abstract]. Nippon Igaku Hoshasen Cakkai Zasshi I995;55:582-586.
34. Thompson CJ, Murthy K, Picard Y, Weinberg IN, Mako R. Positron emission mammography (PEM): a promising technique for detecting breast cancer. IEEE Trans Nucl Sei 1995:42:1012-1017.
35. Weinberg IN, Majewski S, Weisenberger A, et al. Preliminary results for positron emission mammography: real-time functional breast imaging in a conventional mammography gantry. Eur J Nucl Med 1996;23:804-806.
36. Huovinen R, Eeskinen-Kallio S, Nâgren K, Eehikoinen P, Ruotsalainen U, Teräs M. Carbon-11-methionine and PET in evaluation of treatment response of breast cancer. Br J Cancer 1993:67:787-791.